Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. If you like our podcast, please take the time to rate it and subscribe. See our website for more information, video capsules, and podcasts at: https://www.impactmedicom.com.
| Episode | Date |
|---|---|
|
Canadian Hematology Consensus Group: RR FL Consensus Paper Discussion
|
Aug 19, 2026 |
|
Introduction to the Canadian Hematology Consensus Group (CHCG)
|
May 29, 2026 |
|
Double-Exposed CLL/SLL: A Canadian Perspective
|
Dec 02, 2025 |
|
Thoracic Surgery Series: Resection after Neoadjuvant Immunotherapy
|
Nov 10, 2025 |
|
Highlights from EHA/ICML 2025: International Perspective on CLL
|
Jun 26, 2025 |
|
Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH
|
Mar 27, 2025 |
|
Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL
|
Mar 26, 2025 |
|
ASH 2024: Updates on CLL
|
Dec 29, 2024 |
|
Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape
|
Sep 04, 2024 |
|
Highlights from EHA 2024 - Updates on the Treatment of CLL
|
Jul 02, 2024 |
|
LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL
|
Jun 21, 2024 |
|
Cutting Edge Advances in the Treatment of Lung Cancer
|
Apr 19, 2024 |
|
Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers
|
Apr 18, 2024 |
|
Immunotherapy for Kidney Transplant Patients with Skin Cancer
|
Mar 25, 2024 |
|
Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective
|
Mar 25, 2024 |
|
LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM
|
Dec 18, 2023 |
|
Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL
|
Dec 07, 2023 |
|
First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC
|
Oct 26, 2023 |
|
First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion
|
Sep 18, 2023 |
|
First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion
|
Sep 18, 2023 |
|
First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment
|
Sep 18, 2023 |
|
First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs
|
Sep 18, 2023 |
|
Precision Medicine Series: Ep14: External Quality Assurance in Biomarker Testing
|
Jun 19, 2023 |
|
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP4: Hyperglycemia
|
Jun 05, 2023 |
|
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP1: Introduction to EV
|
Apr 28, 2023 |
|
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP2: Skin Reactions
|
Apr 28, 2023 |
|
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP3: Peripheral Neuropathy
|
Apr 27, 2023 |
|
Live from CCOLD - Treatment of CLL
|
Apr 03, 2023 |
|
Live from CCOLD: Dr Davids Discusses the ALPINE Trial in CLL
|
Mar 23, 2023 |
|
Precision Medicine Series: Ep13: Biomarkers in Endometrial Cancer
|
Mar 13, 2023 |
|
Highlights from ASH: Canadian Perspective on the ALPINE Trial in CLL
|
Dec 19, 2022 |
|
ASH Highlights - ALPINE Trial Shows Improved Efficacy and Safety Profile of Zanubrutinib vs Ibrutinib in CLL
|
Dec 13, 2022 |
|
Precision Medicine in Oncology Podcast Series: Ep12. Biomarkers for the treatment of breast cancer
|
Sep 16, 2022 |
|
Treatment of Advanced Urothelial Carcinoma – A Discussion of EV-301
|
Jun 16, 2022 |
|
Immunotherapy for Cervical Cancer
|
May 24, 2022 |
|
Immunotherapy in HNSCC Series: Ep 3 - Role of the Medical Oncologist
|
May 19, 2022 |
|
Precision Medicine in Oncology: Ep.11. Selection and use of PARP inhibitors for first-line maintenance treatment in ovarian cancer
|
May 02, 2022 |
|
Immunotherapy in HNSCC Series: Ep 2 - Perspectives from Surgical Oncology
|
Apr 25, 2022 |
|
Immunotherapy in HNSCC Series: Ep 1 - PD-L1 testing
|
Apr 04, 2022 |
|
Triple Negative Breast Cancer: Immunotherapies and Biomarkers
|
Mar 21, 2022 |
|
Precision Medicine in Oncology: Ep.10. Biomarkers in Gastrointestinal Malignancies
|
Feb 07, 2022 |
|
Precision Medicine in Oncology: Ep.9 DEBATE - Is PARP inhibitor maintenance therapy in first-line BRCA mutated ovarian cancer a curative-intent strategy?
|
Jan 07, 2022 |
|
Precision Medicine in Oncology: Ep.8. Importance of BRCA testing for Advanced Epithelial Ovarian Cancer
|
Dec 07, 2021 |
|
Precision Medicine in Oncology Podcast Series: Ep7. Importance of Genetic Testing in Patients with Prostate Cancer
|
Nov 29, 2021 |
|
Precision Medicine in Oncology: Ep.6 Biomarker testing in metastatic colorectal cancer – mismatch repair and beyond
|
Nov 26, 2021 |
|
Zanubrutinib for the Treatment of Waldenstrom's Macroglobulinemia
|
Oct 22, 2021 |
|
Precision Medicine in Oncology: Ep.5 Precision medicine for metastatic colorectal cancer
|
Sep 27, 2021 |
|
Lung Cancer Screening: Ontario
|
Sep 02, 2021 |
|
Lung Cancer Screening: Western Canada
|
Sep 02, 2021 |
|
Dépistage du Cancer Du Poumon: Québec
|
Sep 02, 2021 |
|
Lung Cancer Screening: National
|
Sep 01, 2021 |
|
Precision Medicine in Oncology: Ep.4 Access to Genomic Profiling in Quebec
|
Jul 13, 2021 |
|
Treatment of Relapsed/Refractory Hodgkin's Lymphoma
|
Jul 09, 2021 |
|
Chronic Lymphocytic Leukemia (CLL): How do we Manage Patients During COVID-19?
|
Oct 28, 2020 |
|
Virtual Patient Management during COVID-19: How can we best Manage Patients with Inflammatory Arthritis?
|
Oct 23, 2020 |
|
The Opioid Epidemic in Canada: What Can We Do?
|
Oct 22, 2020 |
|
COVID-19: Playing Sports Safely with Dr. Ray Deonandan
|
Oct 14, 2020 |